Infection Management Test Offered in Key EU Markets
May 23 2018 Read 874 Times
A point of care (POC) test developed by Mologic for detecting infection in patients on peritoneal dialysis (PD), is to be distributed into key European markets including France, Germany, Italy, the Netherlands, Austria and Switzerland by medical technology companies Medisur and Peripal AG.
Widely accepted as a preferred method for managing end-stage renal disease, PD offers greater patient mobility and independence compared to other dialysis options, as well as being gentler to residual kidney function in early-stage disease. Recurring infection, or peritonitis, however, is a major issue for PD patients.
The PERiPLEX® test detects two critical biomarkers of infection in PD waste fluid using a lateral flow immunoassay system and provides a visual result within 10 minutes. A positive result can give PD patients warning of an infection, prompting them to contact their healthcare provider to initiate antibiotic therapy. Earlier identification of infection would enable pre-emptive use of available antibiotics, resulting in improved management of infection and prevention of infection-related damage to the peritoneal membrane.
Mark Davis, co-founder and CEO at Mologic commented: “Establishing a global distribution network is integral to Mologic’s product commercialisation strategy. With the appointment of distributors across Europe we will ensure PERiPLEX is available to more patients, giving them greater choice and the confidence to monitor their dialysis at home. Medisur and Peripal share our mission to improve the lives of patients by bringing diagnostics and treatment closer to home and with highly complementary product portfolios, we look forward to working together.”
The technology was developed following a collaborative project with Cardiff University Medical School, funded by the National Institute of Health Research (NIHR).
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...
View all digital editions
Jan 28 2019 Dubai International Convention & Exhibition Centre
Jan 30 2019 Tokyo, Japan
Jan 31 2019 Paris, France
Feb 02 2019 Washington, DC, USA.
Feb 04 2019 Dubai, UAE